Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients

mBio

Volumn 6, Issue 2, 2015, Pages

  Watanabe, Yohei ^a,b   Arai, Yasuha ^a   Daidoji, Tomo ^b   Kawashita, Norihito ^a,c   Ibrahim, Madiha S ^d   El Gendy, Emad El Din M ^d   Hiramatsu, Hiroaki ^e   Kubota Koketsu, Ritsuko ^f   Takagi, Tatsuya ^a,c   Murata, Takeomi ^g   Takahashi, Kazuo ^h   Okuno, Yoshinobu ^f   Nakaya, Takaaki ^b   Suzuki, Yasuo ^e   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d DAMANHOUR UNIVERSITY   (Egypt)

^e CHUBU UNIVERSITY   (Japan)

^f The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^g SHIZUOKA UNIVERSITY   (Japan)

^h OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; SIALIC ACID; VIRUS RECEPTOR; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CLADISTICS; CONTROLLED STUDY; EGYPT; EPITHELIUM CELL; FEMALE; GENE MUTATION; HEMAGGLUTININ GENE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H5N1; MEMBRANE FUSION; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BINDING DOMAIN; REVERSE GENETICS; THERMOSTABILITY; VIRUS REPLICATION; ADAPTATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CLASSIFICATION; DISEASE MODEL; GENETIC VARIATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFLUENZA; INFLUENZA A VIRUS (H5N1); ISOLATION AND PURIFICATION; MISSENSE MUTATION; ORTHOMYXOVIRUS INFECTION; SURVIVAL ANALYSIS; VIROLOGY;

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

ADAPTATION, BIOLOGICAL; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MICE, INBRED BALB C; MUTATION, MISSENSE; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS;

EID: 84928821651     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00081-15     Document Type: Article

References (49)

1. García-Sastre A, Schmolke M. 2014. Avian influenza A H10N8—a virus on the verge? Lancet 383:676–677. http://dx.doi.org/10.1016/S0140-6736(14)60163-X.
2. To KK, Tsang AK, Chan JF, Cheng VC, Chen H, Yuen KY. 2014. Emergence in China of human disease due to avian influenza A(H10N8)—cause for concern? J Infect 68:205–215. http://dx.doi.org/10.1016/j.jinf.2013.12.014.
3. Peiris JS, de Jong MD, Guan Y. 2007. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20:243–267. http://dx.doi.org/10.1128/CMR.00037-06.
4. Watanabe Y, Ibrahim MS, Suzuki Y, Ikuta K. 2012. The changing nature of avian influenza A virus (H5N1). Trends Microbiol 20:11–20. http://dx.doi.org/10.1016/j.tim.2011.10.003.
5. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179.
6. Imai M, Kawaoka Y. 2012. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2:160–167. http://dx.doi.org/10.1016/j.coviro.2012.03.003.
7. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
8. Brown JD, Goekjian G, Poulson R, Valeika S, Stallknecht DE. 2009. Avian influenza virusin water: infectivityis dependent on pH, salinity and temperature. Vet Microbiol 136:20–26. http://dx.doi.org/10.1016/j.vetmic.2008.10.027.
9. Scholtissek C. 1985. Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine 3:215–218. http://dx.doi.org/10.1016/0264-410X(85)90109-4.
10. Neumann G, Macken CA, Karasin AI, Fouchier RA, Kawaoka Y. 2012. Egyptian H5N1 influenza viruses—cause for concern? PLoS Pathog 8:e1002932. http://dx.doi.org/10.1371/journal.ppat.1002932.
11. Tharakaraman K, Raman R, Viswanathan K, Stebbins NW, Jayara-man A, Krishnan A, Sasisekharan V, Sasisekharan R. 2013. Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity. Cell 153:1475–1485. http://dx.doi.org/10.1016/j.cell.2013.05.035.
12. Watanabe Y, Ibrahim MS, Ikuta K. 2013. Evolution and control of H5N1. A better understanding of the evolution and diversity of H5N1 flu virus and its host species in endemic areas could inform more efficient vaccination and control strategies. EMBO Rep 14:117–122. http://dx.doi.org/10.1038/embor.2012.212.
13. Perovic VR, Muller CP, Niman HL, Veljkovic N, Dietrich U, Tosic DD, Glisic S, Veljkovic V. 2013. Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission. PLoS One 8:e61572. http://dx.doi.org/10.1371/journal.pone.0061572.
14. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Mizuike R, Hiramatsu H, Sriwilaijaroen N, Takagi T, Suzuki Y, Ikuta K. 2011. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog 7:e1002068. http://dx.doi.org/10.1371/journal.ppat.1002068.
15. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26:107–113. http://dx.doi.org/10.1038/nbt1375.
16. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Ca-strucci MR, Donatelli I, Kawaoka Y. 2000. Early alterations of the receptor-binding properties of H1, H2 and H3 avian influenza virus hem-agglutinins after their introduction into mammals. J Virol 74:8502–8512.
17. Imai M, Herfst S, Sorrell EM, Schrauwen EJ, Linster M, De Graaf M, Fouchier RA, Kawaoka Y. 2013. Transmission of influenza A/H5N1 viruses in mammals. Virus Res 178:15–20. http://dx.doi.org/10.1016/j.virusres.2013.07.017.
18. Linster M, van Boheemen S, de Graaf M, Schrauwen EJ, Lexmond P, Mänz B, Bestebroer TM, Baumann J, van Riel D, Rimmelzwaan GF, Osterhaus AD, Matrosovich M, Fouchier RA, Herfst S. 2014. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell 157:329–339. http://dx.doi.org/10.1016/j.cell.2014.02.040.
19. Carr CM, Chaudhry C, Kim PS. 1997. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A 94:14306–14313. http://dx.doi.org/10.1073/pnas.94.26.14306.
20. Haywood AM, Boyer BP. 1986. Time and temperature dependence of influenza virus membrane fusion at neutral pH. J Gen Virol 67(Pt 12): 2813–2817. http://dx.doi.org/10.1099/0022-1317-67-12-2813.
21. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420–428. http://dx.doi.org/10.1038/nature10831.
22. Yong E. 2012. Mutant-flu paper published. Nature 485:13–14. http://dx.doi.org/10.1038/485013a.
23. Palese P, Wang TT. 2012. H5N1 influenza viruses: facts, not fear. Proc Natl Acad Sci U S A 109:2211–2213. http://dx.doi.org/10.1073/pnas.1121297109.
24. De Graaf M, Fouchier RA. 2014. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J 33:823–841. http://dx.doi.org/10.1002/embj.201387442.
25. Auewarakul P, Suptawiwat O, Kongchanagul A, Sangma C, Suzuki Y, Ungchusak K, Louisirirotchanakul S, Lerdsamran H, Pooruk P, Thitith-anyanont A, Pittayawonganon C, Guo CT, Hiramatsu H, Jampangern W, Chunsutthiwat S, Puthavathana P. 2007. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 81:9950–9955. http://dx.doi.org/10.1128/JVI.00468-07.
26. Walther T, Karamanska R, Chan RW, Chan MC, Jia N, Air G, Hopton C, Wong MP, Dell A, Malik Peiris JS, Haslam SM, Nicholls JM. 2013. Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog 9:. http://dx.doi.org/10.1371/journal.ppat.1003223.
27. Lakadamyali M, Rust MJ, Zhuang X. 2004. Endocytosis of influenza viruses. Microbes Infect 6:929–936. http://dx.doi.org/10.1016/j.micinf.2004.05.002.
28. Murakami S, Horimoto T, Ito M, Takano R, Katsura H, Shimojima M, Kawaoka Y. 2012. Enhanced growth of influenza vaccine seed viruses in Vero cells mediated by broadening the optimal pH range for virus membrane fusion. J Virol 86:1405–1410. http://dx.doi.org/10.1128/JVI.06009-11.
29. DuBois RM, Zaraket H, Reddivari M, Heath RJ, White SW, Russell CJ. 2011. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog 7:e1002398. http://dx.doi.org/10.1371/journal.ppat.1002398.
30. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151. http://dx.doi.org/10.1371/journal.ppat.1003151.
31. Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. 2000. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm 198:139–146. http://dx.doi.org/10.1016/S0378-5173(99)00442-1.
32. Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. 2001. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence inthe mouse lung: identification offunctional themes. Proc Natl Acad Sci U S A 98:6883–6888. http://dx.doi.org/10.1073/pnas.111165798.
33. Keleta L, Ibricevic A, Bovin NV, Brody SL, Brown EG. 2008. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J Virol 82: 11599–11608. http://dx.doi.org/10.1128/JVI.01393-08.
34. Ping J, Keleta L, Forbes NE, Dankar S, Stecho W, Tyler S, Zhou Y, Babiuk L, Weingartl H, Halpin RA, Boyne A, Bera J, Hostetler J, Fedorova NB, Proudfoot K, Katzel DA, Stockwell TB, Ghedin E, Spiro DJ, Brown EG. 2011. Genomic and protein structural maps of adaptive evolution of human influenza A virus toincreased virulence in the mouse. PLoS One 6:e21740. http://dx.doi.org/10.1371/journal.pone.0021740.
35. Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Na-kowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J. 2011. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One 6:e18577. http://dx.doi.org/10.1371/journal.pone.0018577.
36. Cotter CR, Jin H, Chen Z. 2014. A single amino acid in the stalk region of the H1N1pdm influenza virusHA protein affects viral fusion, stability and infectivity. PLoS Pathog 10:e1003831. http://dx.doi.org/10.1371/journal.ppat.1003831.
37. Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ. 2013. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growthinthe upper respiratory tract butis insufficient for transmission in ferrets. J Virol 87:9911–9922. http://dx.doi.org/10.1128/JVI.01175-13.
38. Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, Cox NJ, Paulson JC, Donis RO. 2012. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 422:105–113. http://dx.doi.org/10.1016/j.virol.2011.10.006.
39. Chutinimitkul S, van Riel D, Munster VJ, van den Brand JM, Rimmel-zwaan GF, Kuiken T, Osterhaus AD, Fouchier RA, de Wit E. 2010. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity.J Virol 84:6825–6833. http://dx.doi.org/10.1128/JVI.02737-09.
40. Crusat M, Liu J, Palma AS, Childs RA, Liu Y, Wharton SA, Lin YP, Coombs PJ, Martin SR, Matrosovich M, Chen Z, Stevens DJ, Hien VM, Thanh TT, Nhu le NT, Nguyet LA, Ha do Q, van Doorn HR, Hien TT, Conradt HS, Kiso M, Gamblin SJ, Chai W, Skehel JJ, Hay AJ, Farrar J, de Jong MD, Feizi T. 2013. Changes in the hemagglutinin of H5N1 viruses during human infection—influence on receptor binding. Virology 447:326–337. http://dx.doi.org/10.1016/j.virol.2013.08.010.
41. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y. 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378–382. http://dx.doi.org/10.1038/nature05264.
42. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534–1541. http://dx.doi.org/10.1126/science.1213362.
43. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Daidoji T, Takagi T, Yasunaga T, Nakaya T, Ikuta K. 2012. Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt. J Gen Virol 93:2215–2226. http://dx.doi.org/10.1099/vir.0.044032-0.
44. Miller MS, Palese P. 2014. Peering into the crystal ball: influenza pandemics and vaccine efficacy. Cell 157:294–299. http://dx.doi.org/10.1016/j.cell.2014.03.023.
45. Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, O’Connor DH, Hughes AL, Neumann G, Kawaoka Y, Friedrich TC. 2013. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 4:2636.
46. Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30:3059–3066. http://dx.doi.org/10.1093/nar/gkf436.
47. Watanabe Y, Ohtaki N, Hayashi Y, Ikuta K, Tomonaga K. 2009. Autogenous translational regulation of the Borna disease virus negative control factor X from polycistronic mRNA using host RNA heli-cases. PLoS Pathog 5:e1000654. http://dx.doi.org/10.1371/journal.ppat.1000654.
48. Hidari KI, Murata T, Yoshida K, Takahashi Y, Minamijima YH, Miwa Y, Adachi S, Ogata M, Usui T, Suzuki Y, Suzuki T. 2008. Chemoenzy-matic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology 18:779–788. http://dx.doi.org/10.1093/glycob/cwn067.
49. Watanabe Y, Ibrahim MS, Ellakany HF, Abd El-Hamid HS, Ikuta K. 2011. Genetic diversificationofH5N1 highly pathogenic avian influenza A virus during replication in wild ducks. J Gen Virol 92:2105–2110. http://dx.doi.org/10.1099/vir.0.032623-0.